المؤلفون: Cantu, E., Suzuki, Y., Diamond, J. M., Ellis, J., Tiwari, J., Beduhn, B., Nellen, J. R., Shah, R., Meyer, N. J., Lederer, D. J., Kawut, S. M., Palmer, S. M., Snyder, L. D., Hartwig, M. G., Lama, V. N., Bhorade, S., Crespo, M., Demissie, E., Wille, K., Orens, J., Shah, P. D., Weinacker, A., Weill, D., Wilkes, D., Roe, D., Ware, L. B., Wang, F., Feng, R., Christie, J. D.

مصطلحات موضوعية: lung disease, immune, inflammatory, lung (allograft) function, dysfunction, pulmonology, translational research, science, lung transplantation, ischemia reperfusion injury (IRI), Medicine (General), Health Sciences

وصف الملف: application/pdf

العلاقة: Cantu, E.; Suzuki, Y.; Diamond, J. M.; Ellis, J.; Tiwari, J.; Beduhn, B.; Nellen, J. R.; Shah, R.; Meyer, N. J.; Lederer, D. J.; Kawut, S. M.; Palmer, S. M.; Snyder, L. D.; Hartwig, M. G.; Lama, V. N.; Bhorade, S.; Crespo, M.; Demissie, E.; Wille, K.; Orens, J.; Shah, P. D.; Weinacker, A.; Weill, D.; Wilkes, D.; Roe, D.; Ware, L. B.; Wang, F.; Feng, R.; Christie, J. D. (2016). "Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post–Lung Transplant Primary Graft Dysfunction Risk." American Journal of Transplantation (3): 833-840.; https://hdl.handle.net/2027.42/134189Test; American Journal of Transplantation; Christie JD, Kotloff RM, Ahya VN, et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171: 1312 – 1316.; Lee JC, Christie JD, Keshavjee S. Primary graft dysfunction: Definition, risk factors, short‐ and long‐term outcomes. Semin Respir Crit Care Med 2010; 31: 161 – 171.; Klarstrom Engstrom K, Khalaf H, Kalvegren H, Bengtsson T. The role of Porphyromonas gingivalis gingipains in platelet activation and innate immune modulation. Mol Oral Microbiol 2015; 30: 62 – 73.; Shetty S, Padijnayayveetil J, Tucker T, et al. The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability. Am J Physiol Lung Cell Mol Physiol 2008; 295: L967 – l975.; Sapru A, Curley MA, Brady S, Matthay MA, Flori H. Elevated PAI‐1 is associated with poor clinical outcomes in pediatric patients with acute lung injury. Intensive Care Med 2010; 36: 157 – 163.; Diamond JM, Lederer DJ, Kawut SM, et al. Elevated plasma long pentraxin‐3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. Am J Transplant 2011; 11: 2517 – 2522.; Shah JA, Vary JC, Chau TT, et al. Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis. J Immunol 2012; 189: 1737 – 1746.; Schimming TT, Parwez Q, Petrasch‐Parwez E, Nothnagel M, Epplen JT, Hoffjan S. Association of toll‐interacting protein gene polymorphisms with atopic dermatitis. BMC Dermatol 2007; 7: 3.; Steenholdt C, Andresen L, Pedersen G, Hansen A, Brynskov J. Expression and function of toll‐like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease. Scand J Gastroenterol 2009; 44: 195 – 204.; Wang L, Jia P, Wolfinger RD, et al. Gene set analysis of genome‐wide association studies: Methodological issues and perspectives. Genomics 2011; 98: 1 – 8.; Daud SA, Yusen RD, Meyers BF, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007; 175: 507 – 513.; Suzuki Y, Cantu E, Christie JD. Primary graft dysfunction. Semin Respir Crit Care Med 2013; 34: 305 – 319.; Yusen RD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty‐First Adult Lung and Heart‐Lung Transplant Report—2014; Focus Theme: Retransplantation. J Heart Lung Transplant 2014; 33: 1009 – 1024.; Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 187: 527 – 534.; Katoh S, Honda S, Watanabe T, et al. Atrial endothelial impairment through Toll‐like receptor 4 signaling causes atrial thrombogenesis. Heart Vessels 2014; 29: 263 – 272.; Lo YL, Beckhouse AG, Boulus SL, Wells CA. Diversification of TOLLIP isoforms in mouse and man. Mamm Genome 2009; 20: 305 – 314.; Dowling JK, O’Neill LA. Biochemical regulation of the inflammasome. Crit Rev Biochem Mol Biol 2012; 47: 424 – 443.; Capelluto DG. Tollip: A multitasking protein in innate immunity and protein trafficking. Microbes Infect 2012; 14: 140 – 147.; Jeong E, Lee JY. Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J 2011; 52: 379 – 392.; Cantu E, Lederer DJ, Meyer K, et al. Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation. Am J Transplant 2013; 13: 1898 – 1904.; Meyer NJ, Li M, Feng R, et al. ANGPT2 genetic variant is associated with trauma‐associated acute lung injury and altered plasma angiopoietin‐2 isoform ratio. Am J Respir Crit Care Med 2011; 183: 1344 – 1353.; Diamond JM, Meyer NJ, Feng R, et al. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2012; 186: 546 – 552.; Diamond JM, Akimova T, Kazi A, et al. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction. Am J Respir Crit Care Med 2014; 189: 567 – 575.; Noth I, Zhang Y, Ma SF, et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: A genome‐wide association study. Lancet Respir Med 2013; 1: 309 – 317.; Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O’Donnell CJ, de Bakker PI. SNAP: A web‐based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008; 24: 2938 – 2939.; Carlson CS, Eberle MA, Rieder MJ, et al. Selecting a maximally informative set of single‐nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74: 106 – 120.; Meyer NJ, Feng R, Li M, et al. IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL‐1 receptor antagonist. Am J Respir Crit Care Med 2013; 187: 950 – 959.; Christie JD, Wurfel MM, Feng R, et al. Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma. PLoS One 2012; 7: e28268.; Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome‐wide association studies. Nat Genet 2006; 38: 904 – 909.; Satagopan JM, Elston RC. Optimal two‐stage genotyping in population‐based association studies. Genet Epidemiol 2003; 25: 149 – 157.; Keating BJ, Tischfield S, Murray SS, et al. Concept, design and implementation of a cardiovascular gene‐centric 50 k SNP array for large‐scale genomic association studies. PLoS ONE 2008; 3: e3583.; Shah RJ, Diamond JM, Cantu E, et al. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest 2013; 144: 616 – 622.; Ware LB, Matthay MA, Parsons PE, et al. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007; 35: 1821 – 1828.; Horrevoets AJ. Plasminogen activator inhibitor 1 (PAI‐1): In vitro activities and clinical relevance. Br J Haematol 2004; 125: 12 – 23.; Shah RJ, Bellamy SL, Localio AR, et al. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant 2012; 31: 942 – 949.; Schliekelman P. Statistical power of expression quantitative trait loci for mapping of complex trait loci in natural populations. Genetics 2008; 178: 2201 – 2216.; Schadt EE, Monks SA, Drake TA, et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 2003; 422: 297 – 302.

الإتاحة: https://doi.org/10.1111/ajt.13525Test
https://hdl.handle.net/2027.42/134189Test

المؤلفون: Shah, R. J., Diamond, J. M., Cantu, E., Flesch, J., Lee, J. C., Lederer, D. J., Lama, V. N., Orens, J., Weinacker, A., Wilkes, D. S., Roe, D., Bhorade, S., Wille, K. M., Ware, L. B., Palmer, S. M., Crespo, M., Demissie, E., Sonnet, J., Shah, A., Kawut, S. M., Bellamy, S. L., Localio, A. R., Christie, J. D.

مصطلحات موضوعية: clinical research / practice, lung transplantation / pulmonology, lung (allograft) function / dysfunction, lung failure / injury, Medicine (General), Health Sciences

وصف الملف: application/pdf

العلاقة: Shah, R. J.; Diamond, J. M.; Cantu, E.; Flesch, J.; Lee, J. C.; Lederer, D. J.; Lama, V. N.; Orens, J.; Weinacker, A.; Wilkes, D. S.; Roe, D.; Bhorade, S.; Wille, K. M.; Ware, L. B.; Palmer, S. M.; Crespo, M.; Demissie, E.; Sonnet, J.; Shah, A.; Kawut, S. M.; Bellamy, S. L.; Localio, A. R.; Christie, J. D. (2015). "Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation." American Journal of Transplantation 15(8): 2188-2196.; https://hdl.handle.net/2027.42/112244Test; American Journal of Transplantation; Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232 – 1241.; Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454 – 1459.; Calfee CS, Matthay MA, Eisner MD, et al. Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med 2011; 183: 1660 – 1665.; Shigemura N, Toyoda Y, Bhama JK, et al. Donor smoking history and age in lung transplantation: A revisit. Transplantation 2013; 95: 513 – 518.; Bonser RS, Taylor R, Collett D, et al. Effect of donor smoking on survival after lung transplantation: A cohort study of a prospective registry. Lancet 2012; 380: 747 – 755.; Vickers AJ, Elkin EB. Decision curve analysis: A novel method for evaluating prediction models. Med Decis Making 2006; 26: 565 – 574.; Moons KG, Donders RA, Stijnen T, Harrell FE, Jr. Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol 2006; 59: 1092 – 1101.; van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007. 16: 219 – 242.; Obesity: Preventing and managing the global epidemic. Report of a WHO consultation World Health Organization technical report series 2000; 894: 1 – 253.; Shah RJ, Diamond JM, Cantu E, et al. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest 2013; 144: 616 – 622.; Christie JD, Bellamy S, Ware LB, et al. Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2010; 29: 1231 – 1239.; Christie JD, Bavaria JE, Palevsky HI, et al. Primary graft failure following lung transplantation. Chest 1998; 114: 51 – 60.; Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart‐lung transplant report‐2012. J Heart Lung Transplant 2012; 31: 1073 – 1086.; Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 187: 527 – 534.; Daud SA, Yusen RD, Meyers BF, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006; 175: 507 – 513.; Christie JD, Kotloff RM, Ahya VN, et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171: 1312 – 1316.; Covarrubias M, Ware LB, Kawut SM, et al. Plasma intercellular adhesion molecule‐1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 2573 – 2578.; Christie JD, Shah CV, Kawut SM, et al. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 2009; 180: 1010 – 1015.; Christie JD, Robinson N, Ware LB, et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 1899; 175: 69 – 74.; Diamond JM, Kawut SM, Lederer DJ, et al. Elevated plasma clara cell secretory protein concentration is associated with high‐grade primary graft dysfunction. Am J Transplant 2011; 11: 561 – 567.; Lederer DJ, Kawut SM, Wickersham N, et al. Obesity and primary graft dysfunction after lung transplantation: The Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med 2011; 184: 1055 – 1061.; Pires‐Neto RC, Morales MMB, Lancas T, et al. Expression of acute‐phase cytokines, surfactant proteins, and epithelial apoptosis in small airways of human acute respiratory distress syndrome. J Crit Care 2013; 28.; Fang A, Studer S, Kawut SM, et al. Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis. Chest 2011; 139: 782 – 787.; Hosmer DW, Lemeshow S. Applied logistic regression. 3rd ed. Malden, MA: Wiley‐Interscience; 2000.; Graubard BI, Korn EL. Predictive margins with survey data. Biometrics 1999; 55: 652 – 659.; Lederer DJ, Wilt JS, D'Ovidio F, et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med 2009; 180: 887 – 895.; Greenland S. The need for reorientation toward cost‐effective prediction: Comments on “Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond” by M. J. Pencina et al, Statistics in Medicine (DOI:10.1002/sim.2929). Stat Med 2008; 27: 199 – 206.; Efron B, Tibshirani R. Improvements on Cross‐validation: The 632+ bootstrap method. J Am Stat Assoc 1997; 92: 548 – 560.; Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 1: 527 – 534.; White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011; 30: 377 – 399.

الإتاحة: https://doi.org/10.1111/ajt.13262Test
https://doi.org/10.1002/sim.2929Test
https://hdl.handle.net/2027.42/112244Test

المؤلفون: Shah, R. J., Wickersham, N., Lederer, D. J., Palmer, S. M., Cantu, E., Diamond, J. M., Kawut, S. M., Lama, V. N., Bhorade, S., Crespo, M., Demissie, E., Sonett, J., Wille, K., Orens, J., Weinacker, A., Shah, P., Arcasoy, S., Wilkes, D. S., Christie, J. D., Ware, L. B.

مصطلحات موضوعية: Lung Transplantation, Primary Graft Dysfunction, CC‐16, Acute Lung Injury, Biomarkers, Medicine (General), Health Sciences

وصف الملف: application/pdf

العلاقة: Shah, R. J.; Wickersham, N.; Lederer, D. J.; Palmer, S. M.; Cantu, E.; Diamond, J. M.; Kawut, S. M.; Lama, V. N.; Bhorade, S.; Crespo, M.; Demissie, E.; Sonett, J.; Wille, K.; Orens, J.; Weinacker, A.; Shah, P.; Arcasoy, S.; Wilkes, D. S.; Christie, J. D.; Ware, L. B. (2014). "Preoperative Plasma Club (Clara) Cell Secretory Protein Levels Are Associated With Primary Graft Dysfunction After Lung Transplantation." American Journal of Transplantation 14(2): 446-452.; https://hdl.handle.net/2027.42/102697Test; American Journal of Transplantation; Christie JD, Kotloff RM, Ahya VN, et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171: 1312 – 1316.; Christie JD, Bavaria JE, Palevsky HI, et al. Primary graft failure following lung transplantation. Chest 1998; 114: 51 – 60.; Covarrubias M, Ware LB, Kawut SM, et al. Plasma intercellular adhesion molecule‐1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 2573 – 2578.; Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232 – 1241.; Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454 – 1459.; Panwar R, Venkatesh B, Kruger P, et al. Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: A prospective cohort study. J Hematol Oncol 2009; 2: 43.; Jorens PG, Sibille Y, Goulding NJ, et al. Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J 1995; 8: 1647 – 1653.; Seam N, Meduri GU, Wang H, et al. Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome. Crit Care Med 2012; 40: 495 – 501.; Pires‐Neto RC, Morales MMB, Lancas T, et al. Expression of acute‐phase cytokines, surfactant proteins, and epithelial apoptosis in small airways of human acute respiratory distress syndrome. J Crit Care 2013; 28: 111.e9 – 111.e15.; Thomsen M, Ingebrigtsen TS, Marott JL, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. J Am Med Assoc 2013; 309: 2353 – 2361.; Sims MW, Beers MF, Ahya VN, et al. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. Chest 2011; 140: 489 – 496.; Kropski JA, Fremont RD, Calfee CS, Ware LB. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest 2009; 135: 1440 – 1447.; Lesur O, Langevin S, Berthiaume Y, et al. Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome. Intensive Care Med 2006; 32: 1167 – 1174.; Janssen R, Sato H, Grutters JC, et al. Study of Clara cell 16, KL‐6, and surfactant protein‐D in serum as disease markers in pulmonary sarcoidosis. Chest 2003; 124: 2119 – 2125.; Broeckaert F, Clippe A, Knoops B, Hermans C, Bernard A. Clara cell secretory protein (CC16): Features as a peripheral lung biomarker. Ann N Y Acad Sci 2000; 923: 68 – 77.; Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ 2009; 338: 157 – 160.; Shah RJ, Diamond JM, Cantu E, et al. Use of a simple prediction model improves pre‐transplant risk stratification for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 187: A3773.; Maldonado G, Greenland S. Simulation study of confounder‐selection strategies. Am J Epidemiol 1993; 138: 923 – 936.; Lederer DJ, Kawut SM, Wickersham N, et al. Obesity and primary graft dysfunction after lung transplantation: The Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med 2011; 184: 1055 – 1061.; Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28: 964 – 974.; Hermans C, Petrek M, Kolek V, et al. Serum Clara cell protein (CC16), a marker of the integrity of the air‐blood barrier in sarcoidosis. Eur Respir J 2001; 18: 507 – 514.; Hoffman SA, Wang L, Shah CV, et al. Plasma cytokines and chemokines in primary graft dysfunction post‐lung transplantation. Am J Transplant 2009; 9: 389 – 396.; Lee JC, Christie JD. Primary graft dysfunction. Proc Am Thorac Soc 2009; 6: 39 – 46.; Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364: 1431 – 1440.; Department of Health and Human Services HRaSA, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA. 2012. Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. Transplant Data 1994–2012. 2012.; Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 187: 527 – 534.; Shah RJ, Bellamy SL, Localio AR, et al. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant 2012; 31: 942 – 949.; Diamond JM, Kawut SM, Lederer DJ, et al. Elevated plasma Clara cell secretory protein concentration is associated with high‐grade primary graft dysfunction. Am J Transplant 2011; 11: 561 – 567.; Christie JD, Shah CV, Kawut SM, et al. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 2009; 180: 1010 – 1015.; Christie JD, Robinson N, Ware LB, et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 2007; 175: 69 – 74.

الإتاحة: https://doi.org/10.1111/ajt.12541Test
https://hdl.handle.net/2027.42/102697Test

المؤلفون: Diamond, J. M., Lederer, D. J., Kawut, S. M., Lee, J., Ahya, V. N., Bellamy, Scarlett, Palmer, S. M., Lama, V. N., Bhorade, S., Crespo, M., Demissie, E., Sonett, J., Wille, K., Orens, J., Shah, P. D., Weinacker, A., Weill, D., Kohl, B. A., Deutschman, C. C., Arcasoy, S., Shah, A. S., Belperio, J. A., Wilkes, D., Reynolds, J. M., Ware, L. B., Christie, Jason D.

المساهمون: Division of Pulmonary, Allergy, and Critical Care Medicine, University of Michigan, Ann Arbor, MI, Pulmonary, Allergy, and Critical Care Division, Center for Clinical Epidemiology and Biostatistics, Penn Cardiovascular Institute, Department of Anesthesia and Critical Care, University of Pennsylvania School of Medicine, Philadelphia, PA, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY, Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University, Raleigh‐Durham, NC, Division of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, IL, Division of Pulmonary, Allergy, and Critical Care, University of Pittsburgh, Pittsburgh, PA, Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Johns Hopkins University Hospital, Baltimore, MD, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, Division of Pulmonary and Critical Care Medicine, Stanford University, Palo Alto, CA, Department of Surgery, Johns Hopkins University Hospital, Baltimore, MD, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, Division of Pulmonary, Allergy, Critical Care, and Occupational Medicine, Indiana University School of Medicine, Indianapolis, IN

مصطلحات موضوعية: Idiopathic Pulmonary Fibrosis, Long Pentraxin‐3, Lung Transplantation, Primary Graft Dysfunction, Medicine (General), Health Sciences

وصف الملف: application/pdf

العلاقة: Diamond, J. M.; Lederer, D. J.; Kawut, S. M.; Lee, J.; Ahya, V. N.; Bellamy, S.; Palmer, S. M.; Lama, V. N.; Bhorade, S.; Crespo, M.; Demissie, E.; Sonett, J.; Wille, K.; Orens, J.; Shah, P. D.; Weinacker, A.; Weill, D.; Kohl, B. A.; Deutschman, C. C.; Arcasoy, S.; Shah, A. S.; Belperio, J. A.; Wilkes, D.; Reynolds, J. M.; Ware, L. B.; Christie, J. D. (2011). "Elevated Plasma Long Pentraxin‐3 Levels and Primary Graft Dysfunction After Lung Transplantation for Idiopathic Pulmonary Fibrosis." American Journal of Transplantation 11(11).; https://hdl.handle.net/2027.42/88085Test; American Journal of Transplantation; Iwata T, Philipovskiy A, Fisher AJ, et al. Anti‐type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 2008; 181: 5738 – 5747.; Moreno I, Vicente R, Ramos F, Vicente JL, Barbera M. Determination of interleukin‐6 in lung transplantation: Association with primary graft dysfunction. Transplant Proc 2007; 39: 2425 – 2426.; Diamond JM, Christie JD. The contribution of airway and lung tissue ischemia to primary graft dysfunction. Curr Opin Organ Transplant 2010; 15: 552 – 557.; Millington TM, Madsen JC. Innate immunity and cardiac allograft rejection. Kidney Int 2010; 78 ( Suppl 119 ): S18 – S21.; Millington TM, Madsen JC. Innate immunity in heart transplantation. Curr Opin Organ Transplant 2009; 14: 571 – 576.; Kosieradzki M, Rowinski W. Ischemia/reperfusion injury in kidney transplantation: Mechanisms and prevention. Transplant Proc 2008; 40: 3279 – 3288.; Uchida Y, Ke B, Freitas MC, et al. T‐cell immunoglobulin mucin‐3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4‐dependent manner. Gastroenterology 2010; 139: 2195 – 2206.; Hoffman SA, Wang L, Shah CV, et al. Plasma cytokines and chemokines in primary graft dysfunction post‐lung transplantation. Am J Transplant 2009; 9: 389 – 396.; Peri G, Introna M, Corradi D, et al. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 2000; 102: 636 – 641.; Han B, Haitsma JJ, Zhang Y, et al. Long pentraxin PTX3 deficiency worsens LPS‐induced acute lung injury. Intensive Care Med 2011; 37: 334 – 342.; Mauri T, Coppadoro A, Bellani G, et al. Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity. Crit Care Med 2008; 36: 2302 – 2308.; Covarrubias M, Ware LB, Kawut SM, et al. Plasma intercellular adhesion molecule‐1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 2573 – 2578.; Christie JD, Bellamy S, Ware LB, et al. Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2010; 29: 1231 – 1239.; Christie JD, Shah CV, Kawut SM, et al. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 2009; 180: 1010 – 1015.; Diamond JM, Kawut SM, Lederer DJ, et al. Elevated plasma clara cell secretory protein concentration is associated with high‐grade primary graft dysfunction. Am J Transplant 2011; 11: 561 – 567.; Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232 – 1241.; Kuntz CL, Hadjiliadis D, Ahya VN, et al. Risk factors for early primary graft dysfunction after lung transplantation: A registry study. Clin Transplant 2009; 23; 819 – 830.; Muller B, Peri G, Doni A, et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 2001; 29: 1404 – 1407.; Ortega‐Hernandez OD, Bassi N, Shoenfeld Y, Anaya JM. The long pentraxin 3 and its role in autoimmunity. Semin Arthritis Rheum 2009; 39: 38 – 54.; Weill D, Dey GC, Hicks RA, et al. A positive donor gram stain does not predict outcome following lung transplantation. J Heart Lung Transplant 2002; 21: 555 – 558.

الإتاحة: https://doi.org/10.1111/j.1600-6143.2011.03702.xTest
https://hdl.handle.net/2027.42/88085Test

المؤلفون: Orens, J. B., Shearon, T. H., Freudenburger, R. S., Conte, J. V., Bhorade, S. M., Ardehali, A.

المساهمون: Scientific Registry of Transplant Recipients, University of Michigan, Ann Arbor, MI, USA, UMDNJ‐Robert Wood Johnson Medical School, New Brunswick, NJ, USA, University of California Los Angeles, Los Angeles, CA, USA, Loyola University Medical Center, Maywood, IL, USA, Johns Hopkins University School of Medicine, Baltimore, MD, USA

مصطلحات موضوعية: Patient Survival, Organ Donation, Lung Transplantation, Living Donors, Heart‐Lung Transplantation, Heart Transplantation, Graft Survival, Deceased Donors, Waiting List, SRTR, Medicine (General), Health Sciences

وصف الملف: application/pdf

العلاقة: Orens, J. B.; Shearon, T. H.; Freudenburger, R. S.; Conte, J. V.; Bhorade, S. M.; Ardehali, A. (2006). "Thoracic Organ Transplantation in the United States, 1995–2004." American Journal of Transplantation 6(5p2).; http://hdl.handle.net/2027.42/106749Test; American Journal of Transplantation; Levy D, Kenchaiah S, Larson MG et al. Long‐term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397 – 1402.; Levine GN, McCullough KP, Rodgers AM, Dickinson DM, Ashby VB, Schaubel DE. Analytical methods and database design: Implications for transplant researchers, 2005. Am J Transplant 2006; 6 ( Part 2 ): 1228 – 1242.; Egan T, Murray S, Bustami RT et al. Developing the new lung allocation system in the United States. Am J Transplant 2006; 6 ( Part 2 ): 1212 – 1227.; http://www.unos.org/PoliciesandBylaws/policies/docs/policy_9.docTest. Accessed 24 August 2005.; Barr ML, Bourge RC, Orens JB et al. Thoracic organ transplantation in the United States, 1994–2003. Am J Transplant 2005; 5 ( 4 Pt 2 ): 934 – 949.; Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425 – 1436.; Travaline JM, Cordova FC, Furukawa S, Criner GJ. Discrepancy between severity of lung impairment and seniority on the lung transplantation list. Transplant Proc 2004; 36: 3156 – 3160.; Mahon NG, O'Neill JO, Young JB et al. Contemporary outcomes of outpatients referred for cardiac transplantation evaluation to a tertiary heart failure center: Impact of surgical alternatives. J Card Fail 2004; 10: 273 – 278.; Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twenty‐first official adult lung and heart‐lung transplant report–2004. J Heart Lung Transplant 2004; 23: 804 – 815.; Stevenson LW, Miller LW, Desvigne‐Nickens P et al. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: A subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 2004; 110: 975 – 981.; Hunt SA, Baker DW, Chin MH et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. J Heart Lung Transplant 2002; 21: 189 – 203.

الإتاحة: https://doi.org/10.1111/j.1600-6143.2006.01274.xTest
http://hdl.handle.net/2027.42/106749Test
http://www.unos.org/PoliciesandBylaws/policies/docs/policy_9.docTest. Accessed 24 August 2005.